ARTV
Artiva Biotherapeutics, Inc. Common Stock
NASDAQ: ARTV · HEALTHCARE · BIOTECHNOLOGY
$10.24
+17.43% today
Updated 2026-04-30
Market cap
$255.08M
P/E ratio
—
P/S ratio
8.11x
EPS (TTM)
$-3.43
Dividend yield
—
52W range
$1 – $15
Volume
0.3M
Artiva Biotherapeutics, Inc. Common Stock (ARTV) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |